
Anixa Biosciences ANIX
€ 2.03
-2.08%
Quartalsbericht 2025-Q4
hinzugefügt 09.03.2026
Anixa Biosciences P/E 2011-2026 | ANIX
P/E Jährlich Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00947 | -0.00564 | -0.0154 | -0.0101 | -4.64 | -5.81 | -6.51 | -4.94 | -6.09 | -10.9 | -19.6 | -4.23 | -4.5 | -9.39 | -3.23 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00564 | -19.6 | -5.33 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 203.78 | -0.37 % | $ 22.6 B | ||
|
Celcuity
CELC
|
-30.3 | $ 88.24 | -4.7 % | $ 4.13 B | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 4.88 | 8.44 % | $ 6.49 M | ||
|
Fulgent Genetics
FLGT
|
-8.7 | $ 18.93 | 2.32 % | $ 583 M | ||
|
Castle Biosciences
CSTL
|
-19.5 | $ 21.08 | - | $ 611 M | ||
|
Aspira Women's Health
AWH
|
-0.101 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0644 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
44.1 | $ 144.59 | -4.76 % | $ 11.3 B | ||
|
Illumina
ILMN
|
29.7 | $ 162.47 | 1.52 % | $ 25.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-32.3 | $ 130.7 | 0.45 % | $ 16.4 B | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 23.46 | 3.12 % | $ 1.25 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.606 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-18.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.498 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 100.24 | 0.26 % | $ 6.77 B | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 186.29 | -1.88 % | $ 9.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-0.911 | $ 1.37 | - | $ 411 M | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 465.73 | -0.23 % | $ 13.4 B | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 133.03 | -2.58 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
-13.7 | $ 11.28 | -1.4 % | $ 1.44 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.43 | -2.42 % | $ 410 M | ||
|
National Research Corporation
NRC
|
27.2 | $ 21.28 | 7.75 % | $ 476 M | ||
|
Natera
NTRA
|
-147 | $ 216.5 | -2.84 % | $ 29.6 B | ||
|
Personalis
PSNL
|
-5.3 | $ 9.61 | -1.44 % | $ 858 M | ||
|
Koninklijke Philips N.V.
PHG
|
33.8 | $ 25.67 | -3.13 % | $ 24.3 B | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 7.3 | -1.75 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.02 | -1.51 % | $ 4.64 M | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 67.77 | -3.27 % | $ 4.05 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 268.63 | -0.96 % | $ 22.4 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 482.04 | -2.43 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-6.21 | $ 0.69 | 3.51 % | $ 248 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.17 | -1.29 % | $ 1.99 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M |